Stay updated on ZYESAMI Expanded Access Protocol Clinical Trial
Sign up to get notified when there's something new on the ZYESAMI Expanded Access Protocol Clinical Trial page.

Latest updates to the ZYESAMI Expanded Access Protocol Clinical Trial page
- Check4 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check11 days agoChange DetectedA sitewide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check18 days agoChange DetectedThe site footer revision label changes from v3.7.1 to v3.7.2 while the study page remains an error page.SummaryDifference0.2%

- Check25 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1. The study record page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check46 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record content, indicating restricted access. As a result, the study details and related documents are not accessible on this page.SummaryDifference16%

- Check66 days agoChange DetectedThe study page shows a new revision tag, v3.6.6, replacing the previous v3.6.5, indicating a minor metadata update to the page.SummaryDifference0.1%

Stay in the know with updates to ZYESAMI Expanded Access Protocol Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ZYESAMI Expanded Access Protocol Clinical Trial page.